ESSA Pharma Inc. Quarterly Liabilities, Current in USD from Q3 2019 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: ESSA Pharma Inc. quarterly Liabilities, Current history and growth rate from Q3 2019 to Q3 2024.
ESSA Pharma Inc. Liabilities, Current for the quarter ending September 30, 2024 was $3.3M, a 5.55% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2024	$3.3M	-$194K	-5.55%	Sep 30, 2024	10-K	2024-12-17
Q2 2024	$3.58M	+$167K	+4.91%	Jun 30, 2024	10-Q	2024-08-05
Q1 2024	$4.17M	+$2.03M	+94.5%	Mar 31, 2024	10-Q	2024-05-14
Q4 2023	$3.53M	+$596K	+20.3%	Dec 31, 2023	10-Q	2024-02-13
Q3 2023	$3.5M	+$1.18M	+51.3%	Sep 30, 2023	10-K	2024-12-17
Q2 2023	$3.41M	-$626K	-15.5%	Jun 30, 2023	10-Q	2023-08-08
Q1 2023	$2.15M	-$1.6M	-42.7%	Mar 31, 2023	10-Q	2023-05-09
Q4 2022	$2.94M	-$723K	-19.8%	Dec 31, 2022	10-Q	2023-02-07
Q3 2022	$2.31M	-$1.62M	-41.2%	Sep 30, 2022	10-K	2023-12-12
Q2 2022	$4.03M	+$1.03M	+34.1%	Jun 30, 2022	10-Q	2022-08-04
Q1 2022	$3.75M	+$569K	+17.9%	Mar 31, 2022	10-Q	2022-05-10
Q4 2021	$3.66M	+$1.62M	+79.7%	Dec 31, 2021	10-Q	2022-02-03
Q3 2021	$3.93M	+$2.73M	+227%	Sep 30, 2021	10-K	2022-12-13
Q2 2021	$3.01M			Jun 30, 2021	10-Q	2021-08-16
Q1 2021	$3.18M			Mar 31, 2021	10-Q	2021-05-06
Q4 2020	$2.04M			Dec 31, 2020	10-Q	2021-02-11
Q3 2020	$1.2M	-$4.37M	-78.4%	Sep 30, 2020	10-K	2021-11-18
Q3 2019	$5.57M			Sep 30, 2019	10-K	2020-12-15

* An asterisk sign (*) next to the value indicates that the value is likely invalid.